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Abstract
Background: Prevention and control of ovine enzootic abortion (OEA) can be achieved by
application of a live vaccine. In this study, five sheep flocks with different vaccination and infection
status were serologically tested using a competitive enzyme-linked immunosorbent assay (cELISA)
specific for Chlamydophila (Cp.) abortus over a two-year time period.
Results: Sheep in Flock A with recent OEA history had high antibody values after vaccination
similar to Flock C with natural Cp. abortus infections. In contrast, OEA serology negative sheep
(Flock E) showed individual animal-specific immunoreactions after vaccination. Antibody levels of
vaccinated ewes in Flock B ranged from negative to positive two and three years after vaccination,
respectively. Positive antibody values in the negative control Flock D (without OEA or vaccination)
are probably due to asymptomatic intestinal infections with Cp. abortus. Excretion of the attenuated
strain of Cp. abortus used in the live vaccine through the eye was not observed in vaccinated animals
of Flock E.
Conclusion: The findings of our study indicate that, using serology, no distinction can be made
between vaccinated and naturally infected sheep. As a result, confirmation of a negative OEA status
in vaccinated animals by serology cannot be determined.
Background
Chlamydophila abortus (formerly Chlamydia psittaci sero-
type 1) is the most common infectious bacteria causing
abortion in small ruminants in Switzerland with a previ-
ous study demonstrating that 39% of the examined abor-
tions in sheep and 23% in goats were caused by this agent
[1]. In the Swiss canton of Graubünden, a mountainous
region in the countries' east, the economic losses associ-
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ated with ovine enzootic abortion (OEA) are significantly
higher than in other cantons [2].
Cp. abortus is generally introduced into immunologically
naïve flocks by a latently infected animal with the agent
being subsequently transmitted from aborting ewes via
shedding of large amounts of infectious Chlamydia in the
foetal membranes and in vaginal discharges [3]. In newly
infected flocks, up to 30% of ewes may abort in the last tri-
mester of gestation or give birth to weak or dead lambs.
After abortion, ewes in these flocks may develop a protec-
tive immunity. Subsequent yearly losses in endemically
infected flocks may decrease to a lower level (eg. 5–10%)
with sheep either born into the flock or newly introduced
animals likely to suffer abortions during their initial preg-
nancies [4,5].
Prevention and control of OEA is achieved by vaccination
and/or treatment with oxytetracyclines [6]. Two vaccines
against chlamydial abortion are licensed in Switzerland
by the Federal Veterinary Office (FVO) in Berne. The first
of these available was an egg-grown, formalin-inactivated,
whole-organism vaccine (Ovax Clamidia, Fatro, Italy)
which reduces the incidence of abortion in vaccinated
herds but not completely [7-10]. Since December 2002,
an avirulent, temperature-sensitive, live chlamydia vac-
cine (Ovilis®Enzovax, Intervet, The Netherlands), which is
marketed to induce strong long-lasting protection, has
been made commercially available in Switzerland. The
attenuated strain 1B, which forms the basis of this vaccine,
was obtained from the virulent Cp. abortus strain AB7 by
nitrosoguanidine mutagenesis [11-13].
In 2005, a small pilot study was undertaken to determine
if administration of vaccines to protect sheep flocks from
OEA would result in antibody levels in the complement-
fixation test (CFT) and in the competitive enzyme-linked
immunosorbent assay (cELISA) tests similar to those fol-
lowing natural infection [14]. After vaccination with the
inactivated vaccine (Ovax Clamidia) only one sheep
developed a detectable antibody response. In contrast,
vaccination with the attenuated live vaccine (Ovi-
lis®Enzovax) resulted in detectable antibody titers in all
tested sheep.
The aim of this study is to investigate a larger number of
sheep over a two-year period in the field to compare flock-
level ELISA responses between (a) vaccinated (live vac-
cine), (b) naturally infected and (c) non-infected sheep
flocks. It was anticipated that the follow up study of the
humoral responses could possibly discriminate between
vaccinated and naturally OEA-infected sheep. An addi-
tional objective of the study was to attempt to detect
chlamydiae and/or the attenuated strain of Cp. abortus
used in the live vaccine in conjunctival swabs of sheep.
Results
Serological results and abortion cases
cELISA classifications (frequency and proportion posi-
tive), median titer and respective range of positive classi-
fied sheep in flocks A, B, C, D and E over the four different
investigation dates are shown in Table 1. The comparison
between vaccinated and non-vaccinated animals in Flock
B and E is shown in Table 2. Figure 1 shows the titer ranges
(box plots) of all examined sheep in the five flocks over
the four investigation dates.
All ewes (n = 15) of Flock A were serologically positive
after vaccination showing a high median antibody value
of 91.7%. The median antibody level of positive sheep (n
= 13) decreased marginally to 86.6% in autumn 2005. In
spring 2006 and autumn 2006, the seroprevalence in the
flock was 73% (n = 11). The median antibody value of the
positive sheep was 81.3% (spring 2006) and 82.3%
(autumn 2006).
Box plots of cELISA antibody values of all examined sheep  over the four investigation dates Figure 1
Box plots of cELISA antibody values of all examined 
sheep over the four investigation dates. Some or all ani-
mals in flocks A, B and E were vaccinated at given times (gray 
boxes).
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In spring 2005, two years after the first vaccination, six out
of 14 vaccinated sheep in Flock B had a positive serologi-
cal result (median antibody value 62.9%), whereas two
out of 12 non-vaccinated sheep in the same flock were
positive. The number of positive sheep decreased to three
and two in the vaccinated group (n = 14) in autumn 2005
and spring 2006, respectively. In the non-vaccinated
group, one sheep tested positive in autumn 2005, but
none in spring 2006. In autumn 2006, the number of pos-
itive sheep increased in the vaccinated (n = 6) and non-
vaccinated (n = 2) group, although abortions were not
reported. The mean antibody values in the two groups
were comparable, both being slightly greater than 60%.
Flock C (naturally infected flock) served as the positive
control. The seroprevalence in sheep in spring 2005 was
high at 82% (n = 14). The median antibody value in the
positive group was 82.9%. The seroprevalence remained
continuously high (76%–88%) during the whole study
period and median antibody values in positive sheep were
above 70%. In autumn 2005 newborn lambs were largely
negative and had a significantly lower median antibody
value than older ewes (Kruskal Wallis test, p < 0.05) (data
not shown). The ewe with the confirmed chlamydial
abortion in spring 2005 had positive antibody levels for
the remaining sampling period comparable to the other
animals in the flock (50.5%–77%). The seroprevalence in
goats after confirmed chlamydial abortion in all four ani-
mals in spring 2005 was 100% (n = 4) with a high median
antibody value of 91.6% (data not shown). In contrast to
the sheep, all goats remained serologically positive with
very high antibody values (71.2%–97.5%) over the whole
testing period (data not shown).
Flock D served as the negative control for this study.
Despite this, 21% (n = 13) of the ewes showed positive
results in spring 2005, whereas 44% (n = 28) of the ewes
had negative serological results and 35% (n = 22) of ani-
mals showed questionable readings. The median anti-
body values of the positive animals were 69.5%. Half a
year later, in autumn 2005, 21 animals continued to be
Table 1: Serological results A, B, C, D and E. cELISA positive 
(above cutoff) sheep with frequency, respective proportion (%), 
median titers and titer range.
Flock (n) Parameter Spring 
2005
Autumn 
2005
Spring 
2006
Autum 
2006
AN o .  
positive
15 13 11 11
15 sheep Prop. Pos. 
(%)
1 0 0 8 77 37 3
Median 
titer
91.7 86.6 81.3 82.3
Titer 
range
70.9 – 99.9 55.1 – 99.2 62.0 – 99.0 55.3 – 99.2
BN o .  
positive
8428
26 sheep Prop. Pos. 
(%)
31 16 8 31
Median 
titer
65.0 62.9 58.7 63.9
Titer 
range
61.3 – 72.8 55.1 – 68.1 56.4 – 61.0 55.3 – 77.5
CN o .  
positive
14 13 14 15
17 sheep Prop. Pos. 
(%)1
82 76 82 88
Median 
titer
82.9 72.2 71.3 76.8
Titer 
range
69.1 – 95.2 55.1 – 89.6 57.1 – 94.8 55.4 – 95.8
DN o .  
positive
13 21 29 19
63 sheep Prop. Pos. 
(%)
21 33 46 30
Median 
titer
69.5 69.1 69.4 74.3
Titer 
range
55.1 – 100 55.1 – 93.4 55.6 – 88.6 56.9 – 95.2
EN o .  
positive
26 24 19 24
63 sheep Prop. Pos. 
(%)
42 38 30 38
Median 
titer
73.4 81.2 80.4 81.8
Titer 
range
57.4 – 94.8 56.5 – 96.3 55.2 – 97.6 56.0 – 98.7
1significant difference in % positive (Fishers Exact Test, p = 0.024)
Table 2: Serological results vaccinated vs. non-vaccinated (Flock 
B and E). Comparison of cELISA positive (above cutoff) 
vaccinated and naturally exposed sheep with frequency, 
respective proportion (%), median titers and titer range.
Flock (n) Parameter Spring 
2005
Autumn 
2005
Spring 
2006
Autum 
2006
B1 No. 
positive
6322
14 sheep Prop. Pos. 
(%)
43 22 14 43
Median 
titer
62.9 61.3 58.7 64.5
Titer range 61.3 – 64.2 55.1 – 66.3 56.4 – 61.0 55.3 – 77.5
B2 No. 
positive
2102
12 sheep Prop. Pos. 
(%)
1 7 801 7
Median 
titer
71.1 68.1 - 62.2
Titer range 69.4 – 72.8 - - 55.9 – 68.5
E1 No. 
positive
1001
13 sheep Prop. Pos. 
(%)
8008
Median 
titer
61.4 - - 73.2
Titer range - - - -
E2 No. 
positive
25 24 19 23
50 sheep Prop. Pos. 
(%)
50 48 38 46
Median 
titer
76.3 81.2 80.4 82.2
Titer range 57.4 – 94.7 56.5 – 96.3 55.2 – 97.6 56.0 – 98.7
1vaccinated group
2non-vaccinated groupBMC Veterinary Research 2007, 3:24 http://www.biomedcentral.com/1746-6148/3/24
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serologically positive. In spring 2006, the seroprevalence
increased to 46%, whereas the mean antibody values of
the positive animals were comparable to spring and
autum 2005 (around 69%). In autumn 2006, the number
of serologically positive ewes decreased to 30% (n = 19),
whereas the mean antibody value of positive sheep
increased to 74.3%.
Prior to vaccination in spring 2005, only one animal in
Flock E was positive in the vaccination group (antibody
value 61.4%), whereas 25 sheep (50%) were positive in
the non-vaccinated group (n = 50). All 13 sheep of the
vaccinated group were serologically negative in autumn
2005 and therefore selected for vaccination in winter
2005. The non-vaccinated group showed seroprevalences
between 38–48% from autumn 2005 to 2006 and median
antibody values of positive animals were consistently
between 80.4–82.2%. In comparison to vaccinated sheep
in Flock A, none of the animals vaccinated in winter 2005
were serologically positive in spring 2006. In autumn
2006, one ewe had a positive antibody value of 73.2%,
whereas the other 12 vaccinated sheep had negative (n =
6) or questionable values (n = 6).
Statistical comparison of mean titers
In flocks A (all animals vaccinated), C and D (no animals
in both flocks vaccinated, Figure 1), differences in titer val-
ues between the sampling periods were always highly sig-
nificant in the RM ANOVA model (p < 0.01). In Flock B,
with a vaccination date between sampling periods 2 and
3, both vaccination status and an interaction term
between vaccination and visit were statistically significant
(p < 0.05). In Flock E, in which vaccination took place
before the first sampling, both main effects were signifi-
cant (time: p < 0.05; vaccination status: p < 0.01), while
the interaction term was not.
PCR results of eye swabs
In Flock E, 118 conjunctival swabs were collected before
application of the live vaccine in autumn 2005. No obvi-
ous signs of ocular surface diseases such as conjunctivitis
and keratitis were observed in any animal. IGS-S PCR
screening detected 22 samples that were positive for
chlamydial DNA. Sequencing of these PCR products iden-
tified 18 samples that shared greater than 98% sequence
similarity to Cp. abortus [GenBank: CR848038.1]. One
sample each was revealed to be positive for Cp. pecorum
[GenBank: CPU68434] and Cp. felis [GenBank:
AP006861.1]. The identity of two samples could not be
determined.
Five months after vaccination, in spring 2006, 118 eye
swabs were sampled in the same flock. 12 samples were
tested positive by the IGS-S PCR but all were from non-
vaccinated ewes. Of these samples, 5/12 were positive for
Cp. abortus [GenBank: CR848038.1] while three were pos-
itive for Cp. pecorum [GenBank: CPU68434]. The identity
of four samples could not be determined. None of the vac-
cinated sheep showed a positive IGS-S PCR result and it
was concluded that no excretion of the vaccine strain had
occurred.
Discussion
This study represents the first longterm chlamydial sero-
logical study comparing vaccinated and non-vaccinated
flocks in Switzerland. The investigations were undertaken
in the canton Graubünden, where numerous chlamydial
abortion cases in sheep were previously reported [1] and
the highest seroprevalence (43%) for Cp. abortus in Swiss
cantons was observed [2].
The results obtained from this study confirm the previous
observations of the pilot study [14] that serology (cELISA)
cannot be used to distinguish between sheep vaccinated
with the live attenuated vaccine and naturally-infected
sheep. The antibody value range in the recently vaccinated
Flock A was comparable to Flock C in which acute infec-
tions of Cp. abortus occured at the same time. In Flock A,
very high antibody levels (around 90%) were visible in
every vaccinated sheep (n = 15), whereas antibody levels
of sheep in the previous pilot study were somewhat lower
(around 60%) 21 days post vaccination [14]. As chlamy-
dial abortion was reported in Flock A in the past, sheep
could have been already serologically positive before vac-
cination and the very high antibody levels could represent
an overlay of both abortion and vaccine-associated anti-
body values. The mean antibody value of positive animals
decreased in both flocks (A and C) from spring 2005 to
spring 2006. A chlamydial abortion was diagnosed in one
goat from Flock C in autumn 2006 explaining the increas-
ing seroprevalence and antibody value in this group of
animals at that time. The antibody values in the goats of
Flock C after an acute infection with Cp. abortus were
higher and persisted at a very high level (80 to 90%) over
the observation period compared to the situation in
sheep. No correlation with protection was seen however,
as a chlamydial abortion occurred in a seropositive goat
which had previously aborted. This observation was also
made in other goat flocks in canton Graubünden (R.
Thoma, personal communication). Goats treated with the
live vaccine also aborted. In general, it is known that if
Chlamydiae are introduced in a naive flock, the losses are
much higher in goats (60%) than in sheep (30%). The dif-
ferences between goats and sheep are consistent with pre-
vious records and to date remain unexplained [15,16].
Antibody levels of vaccinated ewes of Flock B ranged from
negative to positive two and three years after vaccination,
respectively. Questionable antibody levels are either
attributed to undiagnosed Cp. pecorum infections [17] orBMC Veterinary Research 2007, 3:24 http://www.biomedcentral.com/1746-6148/3/24
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are possibly due to the vaccination in spring 2003. In a
similar situation to the naturally infected sheep (Flock C),
a slow decrease of antibody values was observed over the
sampling period. This observation strongly suggests that
serology (cELISA) cannot be used to distinguish between
sheep vaccinated with the live attenuated vaccine and nat-
urally-infected sheep as anticipated in the previous pilot
study [14]. As a direct consequence to this, the confirma-
tion of negative OEA status in vaccinated animals by serol-
ogy cannot be made. This is unfortunate as reliable
confirmation is important if an abatement of OEA
through assembly of OEA-free flocks is to be performed as
undertaken by the Sheep and Goat Health Schemes in
England and Wales and the Premium Health Scheme in
Scotland.
Positive antibody values have been observed in the nega-
tive control flock (Flock D), which had not been vacci-
nated and was free from chlamydial abortion. An
explanation for the observations of an increasing anti-
body value amongst this flock is that the animals may
have asymptomatic intestinal infections with Cp. abortus
as presumed in previous studies [17,19]. An alternative
scenario is that the ewes were infected with a less virulent
strain of Cp. abortus, which provokes seroconversion but
no abortion [17,20]. Fluctuations in the antibody levels
could be the result of bacterial shedding during oestrus
which provokes an induction of antibody levels without
causing abortion [21,22]. Unfortunately, little is still
known at this time about the ability of Cp. abortus to per-
sist in animals (and the anatomical location of this per-
sistent infection) compared to other chlamydial species,
which require more investigations.
In Flock E, the serological reaction of 13 selected vacci-
nated sheep and the 50 non-vaccinated sheep in the flock
was evaluated. Surprisingly and in contrast to the observa-
tions in the previous pilot study [14] and in the two vac-
cinated flocks A and B, six of 13 vaccinated sheep of Flock
E showed no seroconversion eight months after vaccina-
tion. Only one ewe had a positive serological result
(73.2%), comparable to the vaccinated sheep of Flock A
and the naturally OEA-infected sheep of Flock C. The
remaining six ewes had questionable antibody levels. The
primary difference between animals in flocks A and E was
the high variability of antibody levels in vaccinated ani-
mals. These results suggest that individual immunoreac-
tions between sheep can vary considerably.
Sampling of conjunctival swabs from sheep in Flock E was
performed to detect and compare the presence of chlamy-
dial DNA before and after vaccination. Furthermore, a
possible excretion of the vaccine through the eye could be
screened with this approach. Although chlamydiae were
frequently detected by PCR in conjunctival swabs of
sheep, the attenuated strain of Cp. abortus used in the live
vaccine was not detected in swabs collected from vacci-
nated sheep. The incidence of Cp. abortus and Cp. pecorum
and even C. suis in clinically healthy non-vaccinated sheep
was previously observed in a recent study [23]. The signif-
icance of this possible new mode of transmission for OEA
needs further investigation.
Conclusion
The findings in our study strongly suggest that serology
(cELISA) cannot be used to distinguish between sheep
vaccinated with the live attenuated vaccine and naturally-
infected sheep. The course of antibody levels, neverthe-
less, can vary between individual animals and flocks.
Compared to sheep, goats displayed higher antibody lev-
els, which persist over a longer time period but do not cor-
relate with protection. The attenuated strain of Cp. abortus
used in the live vaccine was not detected in eye swabs col-
lected from vaccinated sheep.
Methods
Flock details
Five different sheep flocks in the canton Graubünden
were followed over a two-year period with four flock vis-
its. These five flocks were available for the study in spring
2005 through an established collaboration with veteri-
nary authorities in the canton Graubunden.
Due to constant turnover in each flock (i.e. slaughtering of
old or sick ewes, birth of lambs, introduction of new ani-
mals) the number of animals tested all four times was
much lower than the number of individual sheep in the
flock. Details on the five tested flocks (A, B, C, D and E)
over the four investigation dates (spring 2005/06, autumn
2005/06) are provided in Table 3. Briefly, animals of
Flock A were available for serological testing after vaccina-
tion of 15 sheep in spring 2005. History of chlamydial
abortion in autumn 2004 was reported, but none of the
15 sheep in the study suffered an abortion during the
examination period. Ewes (n = 14) of Flock B were vacci-
nated in spring 2003 with the live vaccine because of a
chlamydial abortion outbreak in the vicinity of this flock.
Before and after vaccination, no abortions due to Cp. abor-
tus occurred and, as a result, the owner abandoned a vac-
cination booster two years later. Access to this flock was
possible in spring 2005. Flock C had an average of 11
goats over the four investigation dates, of which four were
available for repeated testing during the four sampling
periods, but the results were not included in the overall
statistical calculations of Flock C. Flock C had confirmed
chlamydial abortions in autumn 2004 (unknown number
of animals) and spring 2005 (one ewe and four goats). No
further chlamydial abortions occurred in this flock after
spring 2005. Animals suffering from abortions were tested
four times during the study. Flock D represented the neg-BMC Veterinary Research 2007, 3:24 http://www.biomedcentral.com/1746-6148/3/24
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ative control flock as no abortion or vaccination occured
during the study period. Sheep in this flock spent summer
together with a flock that had reports of chlamydial abor-
tion in the past. Nevertheless, no abortions in Flock D
were observed during that time. The ewes from Flock E (n
= 63) suffered from chlamydial abortions for many years.
The last confirmed case of chlamydial abortion was docu-
mented in spring 2005. In this flock, selected sheep (n =
13) that were negative by a cELISA screen in autumn 2005
were vaccinated with the live vaccine according to the
instructions of the manufacturer in winter 2005 and
tested two times after vaccination (spring/autumn 2006).
The serology of the non-vaccinated sheep in this flock (n
= 50) was also followed. During the investigations, no
abortion due to Cp. abortus was observed in this flock.
Blood samples were collected from each flock during
spring and autumn of 2005 and 2006 using Vacutainer
tubes Becton Dickinson, Heidelberg, Germany). Four
hours after collection, blood samples were centrifuged at
3000 × g for 10 minutes and stored in Nunc CryoTubes
(Nalge Nunc International, Roskilde, Denmark) at -20°C
until further processing.
cELISA
Serum samples were tested by the competitive enzyme-
linked immunosorbent assay (cELISA) using the mono-
clonal antibody mAb 188 directed against the variable
segments 1 (VS1) and 2 (VS2) of the major outer mem-
brane protein (MOMP) of Cp. abortus, according to the
protocol of Salti-Montesanto et al. [17]. The results of the
cELISA were expressed as 'percentage of inhibition' corre-
sponding to the antibody concentration in the sample.
Inhibition values above 55 per cent were considered pos-
itive for infection with Cp. abortus (positive cut-off)
whereas inhibition values between 30 – 55 per cent were
classified as questionable, attributable to either Cp. abortus
or Cp. pecorum, a widely distributed chlamydial agent in
small ruminants causing diseases such as arthritis/con-
junctivitis and pneumonia syndrome in lambs and also
subclinical intestinal infections [18,19]. Inhibition values
below 30 per cent were assumed to be negative [17,24].
PCR of eye swabs
Conjunctival swabs (Cytobrushes, Berdat Charles, Bour-
roux, Switzerland) were collected from Flock E before and
after vaccination to investigate possible excretion of
chlamydiae and/or the Cp. abortus vaccine strain through
the eye. Before application of the vaccine, conjunctival
swabs from every sheep in the flock (n = 118) were col-
lected in autumn 2005. Five months following vaccina-
tion (spring 2006), the second conjunctival swab samples
were taken from every sheep in the flock (n = 118). Cyto-
brushes were each placed in a 1.5-ml Eppendorf tube and
stored at -80°C until further processing. DNA extraction
from all swabs was performed as described previously
[25] using a commercial DNA extraction kit (DNeasy Tis-
sue Kit®, Qiagen, Hombrechtikon, Switzerland).
The conjunctival swabs were investigated for the presence
of chlamydial DNA by a Chlamydiales-order specific PCR
targeting the intergenic spacer region (IGS) between
chlamydial 16S and the 23S rRNA genes [26] and using
primers cIGS1f (5'-CAA GGT GAG GCT GAT GAC-3') and
cIGS2r (5'-TCG CCT KTC AAT GCC AAG-3'). PCR condi-
tions are described elsewhere [26]. The identity of all pos-
itively tested IGS PCR products was determined by direct
sequencing of the PCR product from both strands.
Sequencing was performed with an ABI Prism 377 DNA
sequencer (Applied Biosystems) or Applied Biosystems
3100 (Synergene Biotech). The obtained sequences were
compared with the sequences available in GenBank using
the BLAST server from the National Center for Biotechnol-
ogy Information [27].
Investigation of abortion cases
Abortion cases in the flocks were further investigated for
the presence of chlamydiae by routine bacteriology and
immunohistochemistry of the placenta and the fetal
organs (lung, liver, kidney) as described elsewhere [28].
Statistical analysis
Ewe ELISA antibody values were initially categorized into
positive, questionable or negative as described previously
Table 3: Flock details
Flock Examinat
ion dates
Average 
no. sheep
Sheep 
tested all 
4 times
Flock 
history
OEA 
status1
Vaccinati
on with 
live 
vaccine
As p r i n g  &  
autumn 
2005/
2006
54 15 chlamydia
l 
abortions 
in 
autumn 
2004
positive 15 sheep 
(spring 
2005)
Bs p r i n g  &  
autumn 
2005/
2006
48 26 chlamydia
l abortion 
outbreak 
nearby in 
2003
negative 14 sheep 
(spring 
2003), no 
vaccinati
on 
booster
Cs p r i n g  &  
autumn 
2005/
2006
452 173 chlamydia
l 
abortions 
(positive 
control)
positive no
Ds p r i n g  &  
autumn 
2005/
2006
105 63 no 
abortions 
(negative 
control)
negative no
Es p r i n g  &  
autumn 
2005/
2006
118 63 chlamydia
l 
abortions 
in the 
past
positive 13 sheep 
(winter 
2005)
1OEA = ovine enzootic abortion
2Average no. goats: 11
3Goats tested all 4 times: 4BMC Veterinary Research 2007, 3:24 http://www.biomedcentral.com/1746-6148/3/24
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[17,24]. For the analysis, questionable and negative
results were both interpreted as negative. Whole flock
response patterns over time were visualized using box
plots. For those sheep that were tested all four times, the
proportion of positive ewes at each time point was com-
pared within each flock using a Fishers Exact Test with
exact p-values. In addition, the mean titers of those sheep
were compared using a repeated measures ANOVA with
animal ID, time (within animal repetition factor), vacci-
nation status (flocks B and E only), and the interaction
between time and vaccination (again only for flocks B and
E).
Data were stored and handled in MS Excel, and analysed
using the statistical software packages NCSS 2004 [29]
and SPSS 14 [30]. The overall level of statistical signifi-
cance was set to 0.05.
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